BridgeMD
New treatment option for Temporomandibular Joint Osteoarthritis
Official title Intra-articular Allocetra in Osteoarthritis of the of the Temporomandibular Joint (TMJ)
ClinicalTrials.gov ID: NCT06748651
What this study is testing
What is Allocetra?
Allocetra is an investigational medicine, given as an injectable medicine, being studied as a potential treatment for temporomandibular joint osteoarthritis.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study is a single center trial to assess the safety and initial efficacy of intra-articular administration of Allocetra to patients with Temporomandibular Joint Osteoarthritis (TMJ-OA)
- Phase 1: an early, usually small safety study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 60
You may be able to join if
- Diagnosed with temporomandibular OA in the target TMJ.
- Inflammatory findings by Magnetic Resonance Imaging (MRI).
- Acceptable blood workup results (CBC, electrolytes, kidney and liver function).
You likely can't join if
- Prior intra-articular injection to the target TMJ within 3 months prior to treatment.
- Any significant injury or surgery to the target TMJ.
- Evidence of active local infection in the vicinity of the target TMJ or clinically significant active infection anywhere in the body.
- Patients with a known neurological disease or rheumatic condition, a major medical condition that would affect quality of life and influence the...
The study team makes the final eligibility decision.
Where it's taking place
- Ramat Gan, Israel
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 60 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ramat Gan, Israel. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.